European Union · Record · QUESTION_WRITTEN_PRIORITY
P-9-2021-005100
Environmental risk assessments of investigational medicinal genetically modified organism products intended to treat or prevent COVID‑19
Introduced
12 November 2021
Last action
—
Status
QUESTION_WRITTEN_PRIORITY
Sponsors
—
Subjects
Discovery layer
Source updated
12 November 2021
Official titles
Authentic titles published by the source. The stored canonical title is not replaced.
1 official language
French
Évaluations des risques pour l’environnement des médicaments expérimentaux génétiquement modifiés destinés à traiter ou à prévenir la COVID-19
Records
Official record P-9-2021-005100 from European Union at European Parliament. Dated 12 November 2021. Status: QUESTION_WRITTEN_PRIORITY.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Environmental risk assessments of investigational medicinal genetically modified organism products intended to treat or prevent COVID‑19
Environmental risk assessments of investigational medicinal genetically modified organism products intended to treat or prevent COVID‑19
QUESTION_WRITTEN_PRIORITY · EN · 17 November 2021
Environmental risk assessments of investigational medicinal genetically modified organism products intended to treat or prevent COVID‑19
QUESTION_WRITTEN_PRIORITY · EN · 17 November 2021
Environmental risk assessments of investigational medicinal genetically modified organism products intended to treat or prevent COVID‑19
QUESTION_WRITTEN_PRIORITY · EN · 17 November 2021
Answer
QUESTION_WRITTEN_ANSWER
Évaluations des risques pour l’environnement des médicaments expérimentaux génétiquement modifiés destinés à traiter ou à prévenir la COVID-19
QUESTION_WRITTEN_PRIORITY · FR · 17 November 2021
Évaluations des risques pour l’environnement des médicaments expérimentaux génétiquement modifiés destinés à traiter ou à prévenir la COVID-19
QUESTION_WRITTEN_PRIORITY · FR · 17 November 2021
Évaluations des risques pour l’environnement des médicaments expérimentaux génétiquement modifiés destinés à traiter ou à prévenir la COVID-19
QUESTION_WRITTEN_PRIORITY · FR · 17 November 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.